159 related articles for article (PubMed ID: 30456676)
1. The Differences in Clinicopathologic and Prognostic Characteristics Between Surgically Resected Peripheral and Central Lung Squamous Cell Carcinoma.
Lin MW; Huang YL; Yang CY; Kuo SW; Wu CT; Chang YL
Ann Surg Oncol; 2019 Jan; 26(1):217-229. PubMed ID: 30456676
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell Carcinomas.
Lin MW; Yang CY; Kuo SW; Wu CT; Chang YL; Yang PC
Ann Surg Oncol; 2016 Sep; 23(9):3071-81. PubMed ID: 27150441
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
[TBL] [Abstract][Full Text] [Related]
7. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses.
Suzuki K; Nagai K; Yoshida J; Nishimura M; Takahashi K; Yokose T; Nishiwaki Y
Cancer; 1999 Nov; 86(10):1976-84. PubMed ID: 10570421
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of morphologic findings for lung squamous cell carcinoma patients.
Gürel D; Ulukuş Ç; Karaçam V; Ellidokuz H; Umay C; Öztop İ; Sarıoğlu S
Pathol Res Pract; 2016 Jan; 212(1):1-9. PubMed ID: 26608418
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
Aktas GE; Karamustafaoğlu YA; Balta C; Süt N; Sarikaya İ; Sarikaya A
Nucl Med Commun; 2018 Nov; 39(11):995-1004. PubMed ID: 30188416
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
[TBL] [Abstract][Full Text] [Related]
15. Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients.
Masuda R; Kijima H; Imamura N; Aruga N; Nakamura Y; Masuda D; Takeichi H; Kato N; Nakagawa T; Tanaka M; Inokuchi S; Iwazaki M
Mol Med Rep; 2012 Nov; 6(5):937-43. PubMed ID: 22940760
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
17. Morphological computed tomography features of surgically resectable pulmonary squamous cell carcinomas: impact on prognosis and comparison with adenocarcinomas.
Koenigkam Santos M; Muley T; Warth A; de Paula WD; Lederlin M; Schnabel PA; Schlemmer HP; Kauczor HU; Heussel CP; Puderbach M
Eur J Radiol; 2014 Jul; 83(7):1275-1281. PubMed ID: 24840477
[TBL] [Abstract][Full Text] [Related]
18. Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer.
Choi YS; Shim YM; Kim J; Kim K
Eur J Cardiothorac Surg; 2002 Nov; 22(5):695-700. PubMed ID: 12414032
[TBL] [Abstract][Full Text] [Related]
19. Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected Cases.
Liang RB; Yang J; Zeng TS; Long H; Fu JH; Zhang LJ; Lin P; Wang X; Rong TH; Hou X; Yang HX
Ann Surg Oncol; 2018 Oct; 25(11):3300-3307. PubMed ID: 30083835
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma.
Che J; Yang Y; Xiao J; Zhao P; Yan B; Dong S; Cao B
Tumour Biol; 2015 Aug; 36(8):6559-68. PubMed ID: 25820701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
